ABSTRACT
BACKGROUND: Non-stenotic intracranial and systemic atherosclerosis are associated with ischemic stroke. We report frequency and response to anticoagulant vs. antiplatelet prophylaxis of patients with embolic stroke of undetermined source (ESUS) who have non-stenotic intracranial atherosclerosis and/or systemic atherosclerosis. METHODS: Exploratory analysis of the international NAVIGATE ESUS randomized trial comparing rivaroxaban 15mg daily with aspirin 100mg daily in 7213 patients with recent ESUS. Among participants with results of intracranial arterial imaging with either computed tomographic angiography (CTA) or magnetic resonance angiography (MRA), the frequency and predictors of non-stenotic intracranial and systemic atherosclerosis and responses to antithrombotic therapy were assessed. RESULTS: Among 4723 participants with available intracranial CTA or MRA results (65% of the trial cohort), the prevalence of intracranial atherosclerosis was 16% (n=739). Patient features independently associated with intracranial atherosclerosis included East Asian region (odds ratio 2.7, 95%CI 2.2,3.3) and cervical carotid plaque (odds ratio 2.3, 95%CI 1.9,2.7), among others. The rate of recurrent ischemic stroke averaged 4.8%/year among those with intracranial atherosclerosis vs. 5.0.%/year for those without (HR 0.95, 95%CI 0.65, 1.4). Among those with intracranial atherosclerosis, the recurrent ischemic stroke rate was higher if assigned to rivaroxaban (5.8%/year) vs. aspirin (3.7%/year), but the difference was not statistically significant (HR 1.6, 95%CI 0.78, 3.3). There was trend for the effect of antithrombotic treatments to be different according to the presence or absence of intracranial atherosclerosis (pinteraction=0.09). Among participants with evidence of systemic atherosclerosis by either history or imaging (n=3820), recurrent ischemic stroke rates were similar among those assigned to rivaroxaban (5.5%/year) vs. aspirin (4.9%/year)(HR 1.1, 95%CI 0.84, 1.5). CONCLUSIONS: East Asia region was the strongest factor associated with intracranial atherosclerosis. There were no statistically significant differences between rivaroxaban and aspirin prophylaxis for recurrent ischemic stroke in patients with non-stenotic intracranial atherosclerosis and/or systemic atherosclerosis.
Subject(s)
Aspirin/administration & dosage , Factor Xa Inhibitors/administration & dosage , Fibrinolytic Agents/administration & dosage , Intracranial Arteriosclerosis/drug therapy , Intracranial Embolism/prevention & control , Peripheral Arterial Disease/drug therapy , Platelet Aggregation Inhibitors/administration & dosage , Rivaroxaban/administration & dosage , Stroke/prevention & control , Aged , Aspirin/adverse effects , Double-Blind Method , Factor Xa Inhibitors/adverse effects , Female , Fibrinolytic Agents/adverse effects , Humans , Intracranial Arteriosclerosis/diagnostic imaging , Intracranial Arteriosclerosis/epidemiology , Intracranial Embolism/diagnostic imaging , Intracranial Embolism/epidemiology , Male , Middle Aged , Peripheral Arterial Disease/diagnostic imaging , Peripheral Arterial Disease/epidemiology , Platelet Aggregation Inhibitors/adverse effects , Prevalence , Recurrence , Risk Assessment , Risk Factors , Rivaroxaban/adverse effects , Stroke/diagnostic imaging , Stroke/epidemiology , Time Factors , Treatment OutcomeABSTRACT
BACKGROUND AND PURPOSE: The associations of individual long-chain n-3 polyunsaturated fatty acids with incident ischemic stroke and its main subtypes are not well established. We aimed to investigate prospectively the relationship of circulating eicosapentaenoic acid, docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) with risk of total ischemic, atherothrombotic, and cardioembolic stroke. METHODS: We measured circulating phospholipid fatty acids at baseline in 3 separate US cohorts: CHS (Cardiovascular Health Study), NHS (Nurses' Health Study), and HPFS (Health Professionals Follow-Up Study). Ischemic strokes were prospectively adjudicated and classified into atherothrombotic (large- and small-vessel infarctions) or cardioembolic by imaging studies and medical records. Risk according to fatty acid levels was assessed using Cox proportional hazards (CHS) or conditional logistic regression (NHS, HPFS) according to study design. Cohort findings were pooled using fixed-effects meta-analysis. RESULTS: A total of 953 incident ischemic strokes were identified (408 atherothrombotic, 256 cardioembolic, and 289 undetermined subtypes) during median follow-up of 11.2 years (CHS) and 8.3 years (pooled, NHS and HPFS). After multivariable adjustment, lower risk of total ischemic stroke was seen with higher DPA (highest versus lowest quartiles; pooled hazard ratio [HR], 0.74; 95% confidence interval [CI], 0.58-0.92) and DHA (HR, 0.80; 95% CI, 0.64-1.00) but not eicosapentaenoic acid (HR, 0.94; 95% CI, 0.77-1.19). DHA was associated with lower risk of atherothrombotic stroke (HR, 0.53; 95% CI, 0.34-0.83) and DPA with lower risk of cardioembolic stroke (HR, 0.58; 95% CI, 0.37-0.92). Findings in each individual cohort were consistent with pooled results. CONCLUSIONS: In 3 large US cohorts, higher circulating levels of DHA were inversely associated with incident atherothrombotic stroke and DPA with cardioembolic stroke. These novel findings suggest differential pathways of benefit for DHA, DPA, and eicosapentaenoic acid.
Subject(s)
Brain Ischemia/blood , Cardiovascular Diseases/blood , Fatty Acids, Omega-3/blood , Intracranial Embolism/blood , Intracranial Thrombosis/blood , Stroke/blood , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Brain Ischemia/diagnosis , Brain Ischemia/epidemiology , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/epidemiology , Case-Control Studies , Cohort Studies , Female , Follow-Up Studies , Humans , Incidence , Intracranial Arteriosclerosis/blood , Intracranial Arteriosclerosis/diagnosis , Intracranial Arteriosclerosis/epidemiology , Intracranial Embolism/diagnosis , Intracranial Embolism/epidemiology , Intracranial Thrombosis/diagnosis , Intracranial Thrombosis/epidemiology , Male , Middle Aged , Prospective Studies , Random Allocation , Risk Factors , Stroke/diagnosis , Stroke/epidemiology , United States/epidemiologyABSTRACT
This study was conducted to investigate the role of different homocysteine metabolism-related vitamin (HMRV) levels in the correlation between hyperhomocysteinemia (HHCY) and ischemic stroke (IS) subtypes. Three hundred and forty-eight IS patients manifesting different vascular subtypes were subclassified on the basis of HMRV deficiencies. Correlation between HHCY and IS subtypes was investigated in all the subgroups. In this study, HHCY was significantly correlated with the IS subtypes in large artery atherosclerosis (OR 1.126, 95%CI: 1.051 ~ 1.206, P = 0.001) and small artery occlusion (OR 1.105, 95%CI: 1.023 ~ 1.193, P = 0.012). Subgroup analysis revealed a correlation between HHCY and IS subgroup (OR 1.201, 1.178, 95%CI: 1.081 ~ 1.334, 1.058 ~ 1.313, P = 0.001, P = 0.003, respectively) in HMRV deficiency, but not significantly with the IS subgroup in normal HMRV levels. Serum vitamin B12 concentrations are inversely correlated with both IS subtypes in HMRV deficiency subgroups (OR 0.992, 0.995, 95%CI: 0.987 ~ 0.996, 0.991 ~ 0.999, P < 0.001, P = 0.007, respectively), which may contribute to HHCY incidence in these populations. The correlation between HHCY and IS subtypes is affected by HMRV levels in this case-control study. Our findings are helpful to understand the inconsistency in prior homocysteine studies. Serum vitamin B12 levels may play a critical role in HHCY incidence in this Chinese population.Cerebrovascular disease has emerged as the leading cause of disability and mortality in both urban and rural areas of China (Neurology branch of Chinese Medical Association 2015). Ischemic stroke (IS) constitutes 60% to 80% of all cerebrovascular disease (Neurology branch of Chinese Medical Association 2014). Among a variety of risk factors, hyperhomocysteinemia (HHCY) has been closely correlated with IS due to intracranial small-vessel disease and extracranial large-artery disease (Selhub et al. 1995; Eikelboom et al. 2000; Alvarez et al. 2012; Jeon et al. 2014). However, the failure to lower homocysteine (HCY) via homocysteine metabolism-related vitamin (HMRV, including folic acid and vitamin B12 but not vitamin B6 in this study) supplementation to reduce stroke morbidity questions the role of HCY as a risk factor for stroke (Lonn et al. 2006; Hankey et al. 2010). Theoretically, HMRV supplementation merely lowers the incidence of stroke induced by HHCY resulting from HMRV deficiency, whereas HHCY-induced stroke concomitant with normal HMRV levels may be refractory to treatment. The correlation between HCY varying with HMRV levels and IS subtypes is still unclear. In this study, we investigated the impact of variation in HMRV levels on the correlation between HHCY and IS subtypes in 348 acute IS patients with large and small vessel diseases. We sought to determine the factors underlying the conflicting results associated with lowering HCY by HMRV supplementation to reduce stroke incidence.
Subject(s)
Folic Acid/blood , Homocysteine/blood , Hyperhomocysteinemia/blood , Intracranial Arteriosclerosis/blood , Kidney/physiology , Stroke/blood , Vitamin B 12/blood , Aged , Aged, 80 and over , Asian People , Case-Control Studies , Cerebrovascular Disorders/blood , Cerebrovascular Disorders/diagnostic imaging , Cerebrovascular Disorders/epidemiology , China/epidemiology , Female , Humans , Hyperhomocysteinemia/diagnostic imaging , Hyperhomocysteinemia/epidemiology , Intracranial Arteriosclerosis/diagnostic imaging , Intracranial Arteriosclerosis/epidemiology , Male , Middle Aged , Retrospective Studies , Stroke/diagnostic imaging , Stroke/epidemiologyABSTRACT
Intracranial atherosclerosis is one of the most common causes of stroke worldwide and is associated with a high risk of recurrent stroke. New therapeutic approaches to treat this high-risk disease include dual antiplatelet treatment, intensive management of risk factors, and endovascular therapy. Early data from randomised trials indicate that aggressive medical therapy is better than stenting for prevention of recurrent stroke in high-risk patients with atherosclerotic stenosis of a major intracranial artery. Nevertheless, there are subgroups of patients who remain at high risk of stroke despite aggressive medical therapy. Further research is needed to identify these high-risk subgroups and to develop more effective treatments. Non-invasive vascular imaging methods that could be used to identify high-risk patients include fractional flow on magnetic resonance angiography (MRA), quantitative MRA, and high-resolution MRI of the atherosclerotic plaque. Alternative therapies to consider for future clinical trials include angioplasty alone, indirect surgical bypass procedures, ischaemic preconditioning, and new anticoagulants (direct thrombin or Xa inhibitors).
Subject(s)
Cerebral Arterial Diseases , Intracranial Arteriosclerosis , Cerebral Arterial Diseases/diagnosis , Cerebral Arterial Diseases/epidemiology , Cerebral Arterial Diseases/therapy , Constriction, Pathologic/diagnosis , Constriction, Pathologic/epidemiology , Constriction, Pathologic/therapy , Humans , Intracranial Arteriosclerosis/diagnosis , Intracranial Arteriosclerosis/epidemiology , Intracranial Arteriosclerosis/therapyABSTRACT
OBJECTIVE: While data on the relationship between fatty acid (FA) composition and the risk for total stroke have accumulated, the association between FA composition and the risk for intracranial atherosclerotic stenosis (ICAS) has never been studied. We compared plasma phospholipid FA composition between non-stroke control and ischemic stroke in Korean population, to discern the FA that distinguishes ICAS from total ischemic stroke patients. METHODS: Non-stroke controls (n = 215) and stroke patients (no cerebral atherosclerotic stenosis, NCAS: n = 144 and ICAS: n = 104) were finally included in the analysis. Plasma phospholipid FA compositions were analyzed. RESULTS: Age, coexistence of hypertension/diabetes were significantly different among the groups. Phospholipid FA compositions were significantly different between non-stroke control and ischemic stroke patients, and interestingly, between NCAS and ICAS in stroke patients. Pattern analysis showed that docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), the ω3-polyunsaturated FAs were important FAs in distinguishing NCAS and ICAS in strokes. Particularly, the risk of ICAS was inversely associated with levels of DHA contents in phospholipids (OR: 0.590, 95% CI: 0.350-0.993, p < 0.05), indicating that the risk may be increased at lower levels of DHA contents. CONCLUSION: DHA and EPA are important FAs for distinguishing NCAS and ICAS in strokes. Additionally, the risk of ICAS was inversely associated with the levels of phospholipid DHA, which indicates that sufficient amounts of DHA in plasma or in diet may reduce the risk of ICAS.
Subject(s)
Brain Ischemia/blood , Docosahexaenoic Acids/blood , Intracranial Arteriosclerosis/blood , Phospholipids/blood , Stroke/blood , Adult , Age Factors , Aged , Biomarkers/blood , Brain Ischemia/diagnosis , Brain Ischemia/epidemiology , Brain Ischemia/prevention & control , Case-Control Studies , Chi-Square Distribution , Comorbidity , Constriction, Pathologic , Dietary Supplements , Docosahexaenoic Acids/therapeutic use , Eicosapentaenoic Acid/blood , Female , Humans , Intracranial Arteriosclerosis/diagnosis , Intracranial Arteriosclerosis/epidemiology , Intracranial Arteriosclerosis/prevention & control , Least-Squares Analysis , Linear Models , Logistic Models , Male , Middle Aged , Multivariate Analysis , Odds Ratio , Principal Component Analysis , Republic of Korea/epidemiology , Risk Assessment , Risk Factors , Stroke/diagnosis , Stroke/epidemiology , Stroke/prevention & controlSubject(s)
Hypertension/epidemiology , Intracranial Arteriosclerosis/epidemiology , Adult , Age Factors , Age of Onset , Brain Ischemia/epidemiology , Causality , Cerebrovascular Circulation , Comorbidity , Humans , Hypothalamus/blood supply , Incidence , Medulla Oblongata/blood supply , Microcirculation , Risk FactorsABSTRACT
OBJECTIVE: To investigate the risk factors of cerebral arteriosclerosis (CAS) in the special population--the old cadre in organizations affiliated directly under Fujian Province. METHODS: The investigation was carried out according to the case control method of epidemiology and conditional logistic regression model was used. RESULTS: Multivariate analysis showed that CAS was closely related with the clinostatic systolic blood pressure (CSBP, OR: 2.13), triglyceride (TG, OR: 2.08), diabetes mellitus (OR: 1.31), glycosylated hemoglobin (OR: 1.16), recall of portrait characteristic (OR: 0.89), Kidney-Deficiency Syndrome (OR: 1.54) and Yin-Deficiency with Yang-Excess Syndrome (OR: 1.59). And there was a quantity-effect relationship between CSBP, TG and CAS. CONCLUSION: CSBP is the most important risk factor of CAS in the special population of the old cadre, and the TCM Syndromes of Kidney-Deficiency and Yin-Deficiency with Yang-Excess are also independent risk factors of CAS.
Subject(s)
Intracranial Arteriosclerosis/epidemiology , Aged , Case-Control Studies , China/epidemiology , Female , Humans , Hypertension/complications , Intracranial Arteriosclerosis/etiology , Logistic Models , Male , Middle Aged , Multivariate Analysis , Risk FactorsABSTRACT
Homocysteine is increasingly recognized as a risk factor for atherothrombotic arterial diseases. We investigated the relation between plasma concentrations of total homocysteine (tHcy) and common carotid artery intima-media wall thickness, measured by B-mode ultrasonography, in 513 asymptomatic men and women from eastern Finland aged 45-69 years. The subjects were examined in 1994-95 at the baseline of the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study, a randomized double-blind placebo-controlled two by two factorial trial on the effect of vitamin E and C supplementation in the prevention of atherosclerotic progression. The subjects were assigned into two categories according to the plasma tHcy concentration; concentration over 11.5 micromol/L (highest quartile) or concentration below 11.5 micromol/L. In this study population the mean plasma tHcy concentration was 10.0 micromol/L, and the prevalence of plasma tHcy concentration exceeding 11.5 micromol/L was 33% in men and 18% in women. The adjusted mean intima-media thickness of the right and left common carotid arteries was 1.12 mm in men with elevated plasma tHcy concentration and 1.02 mm in men with a plasma tHcy concentration below 11.5 micromol/L (P = 0.029). In women there was no significant difference. We conclude that elevated plasma tHcy concentrations are associated with early atherosclerosis, as manifested by increased common carotid artery intima-media wall thickness, in middle-aged eastern Finnish men.
Subject(s)
Arteriosclerosis/diagnostic imaging , Carotid Artery Diseases/diagnostic imaging , Carotid Artery, Common/diagnostic imaging , Homocysteine/blood , Adult , Aged , Arteriosclerosis/epidemiology , Arteriosclerosis/prevention & control , Ascorbic Acid/therapeutic use , Carotid Artery Diseases/epidemiology , Carotid Artery Diseases/prevention & control , Double-Blind Method , Female , Humans , Intracranial Arteriosclerosis/diagnostic imaging , Intracranial Arteriosclerosis/epidemiology , Intracranial Arteriosclerosis/prevention & control , Male , Middle Aged , Risk Factors , Smoking/epidemiology , Ultrasonography , Vitamin E/therapeutic useABSTRACT
BACKGROUND: Evidence that dietary antioxidants may prevent atherosclerotic disease is growing. The relationship between the intake of dietary and supplemental vitamin C, alpha-tocopherol, and provitamin A carotenoids and average carotid artery wall thickness was studied in 6318 female and 4989 male participants 45 to 64 years old int he Atherosclerosis Risk in Communities Study. METHODS AND RESULTS: Intake was assessed by use of a 66-item semiquantitative food-frequency questionnaire. Carotid artery intima-media wall thickness was measured as an indicator of atherosclerosis at multiple sites with B-mode ultrasound. Among men and women > 55 years old who had not recently begun a special diet, there was a significant inverse relationship between vitamin C intake and average artery wall thickness adjusted for age, body mass index, fasting serum glucose, systolic and diastolic blood pressures, HDL and LDL cholesterol, total caloric intake, cigarette use, race, and education (test for linear trend across quintiles of intake, P = .019 for women and P = .035 for men). An inverse relationship was also seen between wall thickness and alpha-tocopherol intake but was significant only in women (test for linear trend, P = .033 for women and P = .13 for men). There was a significant inverse association between carotene intake and wall thickness in older men (test for linear trend, P = .015), but the association weakened after adjustment for potential confounders. No significant relationships were seen in participants < 55 years old. CONCLUSIONS: These data provide limited support for the hypothesis that dietary vitamin C and alpha-tocopherol may protect against atherosclerotic disease, especially in individuals > 55 years old.
Subject(s)
Antioxidants/administration & dosage , Arteriosclerosis/epidemiology , Ascorbic Acid/administration & dosage , Carotenoids/administration & dosage , Carotid Arteries/diagnostic imaging , Diet , Intracranial Arteriosclerosis/diagnostic imaging , Intracranial Arteriosclerosis/epidemiology , Vitamin E/administration & dosage , Arteriosclerosis/prevention & control , Energy Intake , Female , Humans , Intracranial Arteriosclerosis/prevention & control , Male , Middle Aged , Prospective Studies , Risk Factors , Ultrasonography , United States/epidemiology , beta CaroteneSubject(s)
Coronary Disease/epidemiology , Intracranial Arteriosclerosis/epidemiology , Medicine, Chinese Traditional , Medicine, East Asian Traditional , Respiratory Tract Infections/epidemiology , Aged , Blood Urea Nitrogen , Body Weight , China , Female , Follow-Up Studies , Humans , Male , PrognosisABSTRACT
Features peculiar to actual nutritional pattern (in family) of persons of advanced and old age in physiological ageing were studied. According to a fairly broad range of characteristics (cardio-vascular function, blood coagulation system, lipids metabolism parameters, body weight, general clinical diagnosis, etc.) their health status was determined. The alimentation of the examined is shown to be characterized by marked individual peculiarities. On the whole it conforms to the existing recommendations, although there is noted a certain deficiency of proteins, vitamins and mineral elements. Differences in the nutrition of males and females were established. The calorific value of the nutrition declines parallel with the increasing age. Its comparison with the health characteristics of the examined testifies to the presence of a close relationship between them. More favourable indices of the bioelectric activity of the heart, myocardial contractility, the trends in the lipids metabolism, body weight, the blood clotting activity were registered in persons with reduced calorific value of the alimentation.